Skip to content
Search

Latest Stories

Transform your pharmacy into a specialist vaccinations hub

Travel Health and Immunisation was one of the fastest-growing businesses in the health sector until the pandemic hit in 2019/2020. For a successfully operating pharmacy travel clinic, the average takings for Travel Health and Immunisations were between £1,000 and £3,000 per week.

As the demand diminished during the pandemic, other immunisations emerged, such as Occupational Health Vaccinations and Childhood Immunisations. At more specialist pharmacies, we operated BCG Vaccinations and Mantoux Test services.


001 Alex LEUNG PROFILE PHOTO

Now, the engine of global travel has been restarted. However, around 80 per cent of GP surgeries have stopped offering a Travel Vaccination service at the Primary Care level.

This means there has never been a better time to plan and begin offering a Travel Vaccination service at your pharmacy.  A Travel Health service is not just for vaccinations and antimalarials, even though this is what the majority of pharmacy owners have been focusing on.

From a purely business standpoint, vaccinations and antimalarials bring in a substantial revenue; however, the true picture is much broader.

Yellow fever centre

One example I always love to share is the importance of setting up a Yellow Fever Centre

within a community pharmacy travel clinic. Most pharmacists just beginning their Travel Health service prefer a ‘wait and see’ approach, since Yellow Fever vaccinations are regulated by National Travel Health Network and Centre (NaTHNaC) and only their approved centres can provide this vaccination and are authorised to issue a certificate.

To open a Yellow Fever centre, the pharmacy would need to register with NaTHNac via the Yellow Fever Zone online system.

The pharmacist is also required to register with the NaTHNac Training Portal. All pharmacists who provide a Yellow Fever vaccination service must complete NaTHNac training every two years, based on their clinical governance. There is a cost incurred for both processes.

The cost of a Yellow Fever vaccine (Stamaril) is about £39. Most pharmacy travel clinics charge between £59 and £69 per vaccine; therefore, the profit per dose is £20-£30.

Some beginner travel clinics believe the registration process is too much trouble to go through to earn this profit, but this is a strategic mistake.

I have been a Responsible Supervising Clinician (RSC) at more than one hundred pharmacy-based Yellow Fever Centres in the UK. Experience has taught me that for each patient coming in for a Yellow Fever vaccination, an antimalarial tablet, Hepatitis A, Typhoid, Tetanus vaccinations (since most GPs has stopped their travel clinic) are requested, along with other travel health products such as mosquito repellents and anti sickness tablets.

Patients come in for a Yellow Fever vaccination, but walk out with all of these associated products, sometimes resulting in a profit of £300-£400 per person. If patients come as a couple or with their families, this profit can be multiplied by as much as a factor of six.

The Yellow Fever vaccination service is just one of the many Travel Health services that has a huge business potential providing you plan your business strategy correctly.

Clinical implications

A Yellow Fever vaccination does carry a risk if the patient is within certain at-risk groups, such as the over-60s. Typically, a risk and benefit evaluation is carried out, and both sides of the argument should be presented to the patient, enabling them to make their own informed decision whether to vaccinate or not.

Some countries in Africa and South America require a Yellow Fever certificate before the patient is allowed to enter the country. Most patients feel they would need to vaccinate to obtain the mandatory Yellow Fever certificate, but what most pharmacists fail to present is the alternative, i.e., an exemption certificate. As a Yellow Fever Centre, we have the power to issue exemption certificates on medical grounds.

As an experienced Travel Health practitioner, it is my job to ensure both sides of the arguments are presented to enable the patient to make an informed decision.

This is what makes being a specialist in Travel Medicine interesting and fun!

Occupational health vaccines

There has been a rapid growth in the demand for Occupational Health vaccination services in the UK. There are a number of professions that require certain vaccinations (including Tetanus, MMR, Hepatitis B, BCG, Varicella (Chickenpox or Shingles) and Influenza) before roles can be commenced.

Pharmacists should be equipped with the necessary skills and, more importantly, knowledge of the conditions, requirements and follow-ups of certain professions who require specific vaccinations.

Planned correctly, Occupational Health vaccination services could grow to become bigger than Travel Health services. There are three specialist pharmacists in the UK providing BCG vaccination services, but there is only one teaching this subject! It is time for you to receive specialist training in Occupational Health vaccinations within a community pharmacy.

Childhood immunisations

I personally trained a small number of community pharmacies in Childhood Immunisations which have started to provide Childhood Immunisations privately and which have achieved a good level of business.

A specialist vaccinations service, with expert support from your training provider, along with the vision and strategy to support your community pharmacy to upskill and upgrade your pharmacy into a specialist vaccinations hub, is possible, enabling you to pivot from being a Covid vaccinations centre into a complete, specialist vaccination service within community pharmacy. All our instructors are frontline clinicians who practice what we preach.

Next Steps

This is the most exciting time to begin offering a complete immunisation service.

You should:

1. Complete or renew your training in all immunisation services, including Travel Medicine, Occupational Health and Childhood Immunisations, with a specialist training provider.

2. Set up your Yellow Fever Centre in your pharmacy ASAP. Voyager Medical can support your application with our technical support team taking you through the process step-by-step.

3. Plan and execute your Specialist Vaccinations Service with expert training provider Voyager Medical, specialised in all areas of vaccination services.

The time is now. Start your Specialist Immunisations Service in your pharmacy today.

(Alex Leung is owner and clinical director of Voyager Medical, London regional adviser of Royal College of Physicians and Surgeons of Glasgow and chief pharmacist at Shell UK.)

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less